CRP and COVID-19: The hospitalized COVID-19 patients with statins showed a lower mean of C-reactive protein (103 mg/L vs. 124.7 mg/L, p < 0.001) D-dimer (2.4 μg/mL vs. 2.8 μg/mL, p 0.37), and WBC count (7.8 × 103/μL vs. 8.5 × 103/μL, p < 0.01), in comparison to non-statin users.